SCHEMBL19904498

SCHEMBL19904498

O=C(NC(Cc1cc(F)c2c(c1)OCCO2)CN1CCCC1)[C@@H]1CCN(c2ccc3cc(F)ccc3c2)C1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.37
UGCG Q16739 1/20 0.36
CCR3 P51677 3/20 0.33
SSTR3 P32745 4/20 0.33
USP2 O75604 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
MAPK1 P28482 1/20 0.33
HTT P42858 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HSD17B10 Q99714 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
NOTUM Q6P988 2/20 0.33
HTR1A P08908 1/20 0.33
SSTR1 P30872 1/20 0.32
HTR1D P28221 1/20 0.32
SLC6A4 P31645 1/20 0.32
ACACB O00763 3/20 0.32
TRPV1 Q8NER1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19904324 0.98 KDM4E (0.37) KDM4EUGCGCCR3SSTR3NOTUM
SCHEMBL19904535 0.98 KDM4E (0.37) KDM4EUGCGCCR3SSTR3NOTUM
SCHEMBL19904561 0.94 MCHR1 (0.36) UGCGHTR1A
SCHEMBL19904389 0.93 UGCG (0.40) KDM4EUGCGSSTR3USP2ALDH1A1
SCHEMBL19904542 0.93 UGCG (0.40) KDM4EUGCGSSTR3USP2ALDH1A1
SCHEMBL19904593 0.93 MCHR1 (0.36) HTR1A
SCHEMBL19904455 0.91 KMT2A (0.36) KDM4ESSTR3ALDH1A1MAPK1SMN1; SMN2
SCHEMBL19904590 0.91 KMT2A (0.36) KDM4ESSTR3ALDH1A1MAPK1SMN1; SMN2
SCHEMBL19904326 0.90 KDM4E (0.43) KDM4ECCR3SSTR3USP2ALDH1A1
SCHEMBL19904458 0.90 KDM4E (0.43) KDM4ECCR3SSTR3USP2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3063141-B1 N-(1-HYDROXY-3-(PYRROLIDINYL)PROPAN-2-YL)PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS BIOMARIN PHARM INC (US) 2018-02-28 EP disclosed